PublicationsThe U4 Blog

U4 Issue

Good governance for medicines initiatives: Exploring lessons learned

Select global initiatives in the area of good governance and medicines have been particularly useful in generating a political and policy dialogue around the issue of pharmaceutical system good governance. The initiatives examined in this paper have been taken by the World Bank, the WHO and the Global Fund, as well as the Medicines Transparency Alliance. The main findings include that these initiatives identify weaknesses in the pharmaceutical system and can provide important baseline data. Recommendations include the need for political analysis, monitoring and evaluation, and the streamlining and uniformity of assessment tools across institutions.

Also available in Spanish
16 May 2013
Read onlineDownload PDF
Good governance for medicines initiatives: Exploring lessons learned

Cite this publication


Kohler, J.; Ovtcharenko, N.; (2013) Good governance for medicines initiatives: Exploring lessons learned. Bergen: U4 Anti-Corruption Resource Centre, Chr. Michelsen Institute (U4 Issue 2013:3)

Read onlineDownload PDF
Jillian Clare Kohler
Natalia Ovtcharenko

Disclaimer


All views in this text are the author(s)’, and may differ from the U4 partner agencies’ policies.

This work is licenced under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND 4.0)

Photo